Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

4basebio Plc (4BB) Share Price

Price 517.00p on 13-03-2026 at 19:40:05
Change 0.00p 0%
Buy 550.00p
Sell 484.00p
Last Trade: Buy 26.00 at 537.50p
Day's Volume: 27
Last Close: 517.00p
Open: 517.00p
ISIN: GB00BMCLYF79
Day's Range 517.00p - 517.00p
52wk Range: 517.00p - 1,200.00p
Market Capitalisation: £80.06m
VWAP: 537.50p
Shares in Issue: 15.48m

4basebio Plc (4BB) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 26 537.50p Ordinary
09:07:11 - 13-Mar-26
Buy* 1 537.50p Ordinary
09:06:45 - 13-Mar-26
Buy* 300 550.00p Ordinary
15:11:59 - 11-Mar-26
Buy* 300 545.00p Ordinary
12:39:47 - 11-Mar-26
Buy* 7 537.50p Ordinary
11:43:33 - 11-Mar-26
Unknown* 0 484.00p SI Trade
10:15:15 - 11-Mar-26
Unknown* 0 484.00p SI Trade
10:15:15 - 11-Mar-26
Buy* 83 537.50p Ordinary
09:23:43 - 11-Mar-26
Sell* 564 501.6324p Ordinary
13:21:50 - 09-Mar-26
Sell* 600 502.50p Ordinary
13:21:25 - 09-Mar-26
See more 4basebio Plc trades

4basebio Plc (4BB) Share Price History

Time period:
to
Date Open High Low Close Volume
13th Mar 2026 (Fri) 517.00 517.00 517.00 517.00 27
12th Mar 2026 (Thu) 517.00 517.00 517.00 517.00 0
11th Mar 2026 (Wed) 517.00 517.00 517.00 517.00 733
10th Mar 2026 (Tue) 517.00 517.00 517.00 517.00 0
9th Mar 2026 (Mon) 525.00 525.00 525.00 525.00 3,393
6th Mar 2026 (Fri) 540.00 540.00 540.00 540.00 18
5th Mar 2026 (Thu) 540.00 540.00 540.00 540.00 7
4th Mar 2026 (Wed) 540.00 540.00 540.00 540.00 1,549
3rd Mar 2026 (Tue) 540.00 540.00 540.00 540.00 100
2nd Mar 2026 (Mon) 550.00 580.00 580.00 580.00 619
27th Feb 2026 (Fri) 550.00 550.00 550.00 550.00 19
26th Feb 2026 (Thu) 550.00 550.00 550.00 550.00 69
25th Feb 2026 (Wed) 550.00 550.00 550.00 550.00 775
24th Feb 2026 (Tue) 550.00 550.00 550.00 550.00 3,496
23rd Feb 2026 (Mon) 550.00 550.00 550.00 550.00 34
20th Feb 2026 (Fri) 555.00 555.00 550.00 555.00 1,163
19th Feb 2026 (Thu) 555.00 555.00 555.00 555.00 152
18th Feb 2026 (Wed) 555.00 555.00 555.00 555.00 10,275
17th Feb 2026 (Tue) 565.00 565.00 555.00 555.00 1,074
16th Feb 2026 (Mon) 565.00 565.00 565.00 565.00 598
See more 4basebio Plc price history

4basebio Plc (4BB) Regulatory News

Date Source Headline
12th Mar 2026 7:00 am PRN Appointment of COO
3rd Mar 2026 7:00 am PRN Appointment of CCO
16th Feb 2026 7:00 am PRN Director Dealing
11th Feb 2026 3:58 pm PRN Director Dealing
10th Feb 2026 7:00 am PRN Leadership Changes
27th Oct 2025 7:00 am PRN Synthetic opDNA® utilised in Phase I/II US clinical trials
10th Oct 2025 11:30 am PRN Result of Extraordinary General Meeting
30th Sep 2025 4:20 pm PRN Director Dealing
29th Sep 2025 7:00 am PRN Half-year Report
22nd Jul 2025 7:00 am PRN Employee Long Term Incentive Plan and Issue of Equity
See more 4basebio Plc regulatory news

4basebio Plc (4BB) Share News

IN BRIEF: 4basebio appoints Scott Lorimer as chief operating officer

12th Mar 2026 14:31

4basebio PLC - Cambridge, England-based life sciences company - Appoints Scott Lorimer as chief operating officer, with immediate effect. This follows the appointment last week of Christine Wolosin as chief commercial officer, and of Amy Walker last month as chief executive. 4basebio says he will be responsible for scaling its synthetic DNA platform to serve its client base in the cell and gene therapy, mRNA, and vaccine markets. He will also oversee manufacturing operations, quality and regulatory compliance, process development, and supply chain and facility management. Read More

4basebio promotes Christine Wolosin to chief commercial officer

9th Mar 2026 06:58

(Alliance News) - 4basebio PLC on Tuesday announced the promotion of Business Development Vice President Christine Wolosin to chief commercial officer, following the appointment of Amy Walker to chief executive last month. Read More

4basebio promotes COO Amy Walker to CEO, CFO Roth to step down

10th Feb 2026 15:02

(Alliance News) - 4basebio PLC on Tuesday said it has promoted Chief Operating Officer Amy Walker to chief executive officer, succeeding founder Heikki Lanckriet. Read More

4basebio says "tier one" partner tests vaccine from its template

27th Oct 2025 12:40

(Alliance News) - 4basebio PLC on Monday said its synthetic DNA product has been used in US clinical trials by a "global tier one" pharmaceutical partner. Read More

EARNINGS: Next 15 profit falls; 4basebio and Mollyroe losses widen

1st Oct 2025 12:57

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and Tuesday and not separately reported by Alliance News: Read More

See more 4basebio Plc news
FTSE 100 Latest
Value10,261.15
Change-44.00

Login to your account

Forgot Password?

Not Registered